Motor and cognitive delay in Duchenne muscular dystrophy: Implication for early diagnosis

Journal of Pediatrics

Volumn 165, Issue 5, 2014, Pages 1008-1010

  Mirski, Kara T ^a   Crawford, Thomas O ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; CHILDHOOD DISEASE; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE SEVERITY; DUCHENNE MUSCULAR DYSTROPHY; EARLY DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; RETROSPECTIVE STUDY; WALKING DIFFICULTY; CHILD; COGNITION DISORDERS; COMPLICATION; DEVELOPMENTAL DISABILITIES; PRESCHOOL CHILD; REGRESSION ANALYSIS; WALKING;

CHILD; CHILD, PRESCHOOL; COGNITION DISORDERS; DEVELOPMENTAL DISABILITIES; EARLY DIAGNOSIS; HUMANS; MALE; MUSCULAR DYSTROPHY, DUCHENNE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; WALKING;

EID: 84908334398     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2014.07.006     Document Type: Article

References (8)

1. A. Emery, and F. Muntoni Duchenne Muscular Dystrophy 3rd ed. 2003 Oxford University Press Oxford
2. Centers for Disease Control and Prevention (CDC) Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years - four states, 2007 MMWR Morb Mortal Wkly Rep 58 2009 1119 1122
3. L. Merlini, A. Cicognani, E. Malaspina, M. Gennari, S. Gnudi, and B. Talim Early prednisone treatment in duchenne muscular dystrophy Muscle Nerve 27 2003 222 227
4. K. Arcara, and M. Tschudy The Harriett Lane Handbook: A manual for pediatric house officers 19th ed. 2012 Elsevier Philadelphia
5. M. Shevell, S. Ashwal, D. Donley, J. Flint, M. Gingold, and D. Hirtz Practice parameter: evaluation of the child with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society Neurology 60 2003 367 380
6. E.C. Klatt, E.S. Wasef, and E.T. Wong Creatine kinase in a biochemical test panel: the high cost of a seemingly inexpensive test Am J Clin Pathol 77 1982 280 284
7. A.G. Douglas, and M.J. Wood Splicing therapy for neuromuscular disease Mol Cell Neurosci 56 2013 169 185
8. US Department of Health and Human Service: Agency for Healthcare Research and Quality. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. http://guideline.gov/content.aspx?id=15645. Accessed May 1, 2014.